Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could magnetic pulses to the brain help mothers bond better?

NCT ID NCT06743724

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study investigates whether repeated transcranial magnetic stimulation (rTMS) can improve maternal care in mothers who score low on a caregiving scale. Participants receive either real or sham rTMS to a brain region linked to caregiving, while brain scans track changes. The goal is to see if this non-invasive technique can enhance nurturing behaviors and emotional responses.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
repetitive transcranial magnetic stimulation (rTMS)
What this could lead to
If effective, rTMS could offer a non-drug treatment to help mothers with impaired caregiving abilities, potentially improving mother-child bonding.
What could go wrong
This is a small, early-stage trial with only 45 participants. The sham control group may show similar effects, and results may not apply to all mothers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

45 people

The number who actually took part.

Started

Jun 2024

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy mothers. * Aged between 18 and 45 years. * No pharmacological treatment (excluding emergency treatment) for at least 2 weeks prior to the start of treatment; cannot be enrolled in other clinical trials simultaneously. * Voluntarily sign the informed consent form and willingly participate in the clinical study. Exclusion Criteria: * Age below 18 years or above 45 years. * Unmarried, nulliparous women. * Individuals with severe liver, kidney, hematological diseases, cardiovascular diseases, or other conditions that significantly affect cognitive function. * Participants with a clear history of organic diseases, or systemic conditions such as diabetes, hyperthyroidism, etc. * Participants undergoing other treatments or taking medications that may interfere with the outcome assessment. * Pregnant women, breastfeeding women, or women within six months postpartum. * Individuals with severe needle phobia, metal allergies, or allergic conditions, or those with a cardiac pacemaker. * Participants who do not comply with random group assignment or have unstable tendencies such as poor adherence. * Individuals currently participating in other research studies. * Individuals unwilling to sign the informed consent form.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Functional magnetic resonance imaging are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The First Affiliated Hospital of Soochow University

    Suzhou, China, 215006, China

  • The First Affiliated Hospital of Soochow University

    Suzhou, Jiangsu, 215006, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.